S. Borgmann et al., PATHOPHYSIOLOGY, EPIDEMIOLOGY AND THERAPY OF DISTAL RENAL TUBULAR-ACIDOSIS, Nieren- und Hochdruckkrankheiten, 27(2), 1998, pp. 59-66
The present study is a review of interactions between the Sjogren synd
rome and distal renal tubular acidosis (dRTA). In addition, we describ
e the pathophysiology of the dRTA and the diagnosis and the therapy of
the disease. The reason for dRTA accompanying a Sjogren syndrome is t
he absence of proton pumps the renal collecting duct. In serum from wo
men suffering from renal stones, antinuclear autoantibodies specific f
or the Sjogren syndrome (Ro (anti-SS-A), La (anti-SS-B)) often can be
demonstrated, even when the women do not express the typical symptoms
of the Sjogren syndrome. An incomplete dRTA, not apparent in the blood
gas composition, also can lead to the formation of renal stones. In t
his case diagnosis can be made, even in laboratories which do not have
the capacity for NH4+ measurement by measuring the urinary ''osmotic
gap'' or the ''anionic gap'', and with the aid of acidification tests.
Treatment should be with citrate-containing drugs. Calcium-containing
drugs do not facilitate stone formation but, indeed, may prevent the
development of the osteoporosis often seen in dRTA. Calcium-low diets
are contraindicated for the same reason. The present study includes a
report of a case in which, for the first time, the dRTA due to Sjogren
syndrome is accompanied by decreased serum cholinesterase activity.